Listen: Gene therapy’s safety scare & biotech’s brashest VCs

Bozz District

How safe is gene therapy? Is there anything “unique” about venture capital? And who’s going to run the FDA? We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we break down a significant setback for Bluebird Bio’s gene therapy program with some help […]

How safe is gene therapy? Is there anything “unique” about venture capital? And who’s going to run the FDA?

We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we break down a significant setback for Bluebird Bio’s gene therapy program with some help from Akshay Sharma, a bone marrow transplant expert at St. Jude Children’s Research Hospital. Then, STAT’s Kate Sheridan joins us to discuss her deep dive into Flagship Pioneering, the superlatively successful and frequently grandiose venture firm behind Moderna. Finally, we dig into what the future might hold for a post-Trump FDA, which remains without a permanent commissioner.

For more on what we cover, here’s the latest on Bluebird; here’s the story on Flagship; here’s more on the race for FDA commissioner; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the coronavirus pandemic.

advertisement

Be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

advertisement


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].

Next Post

Can a Vaccinated Person Still Spread the Coronavirus?

1. Why is this important? While getting vaccinated gives people considerable insurance against falling ill with Covid, which is sometimes fatal, it’s so far no assurance that they won’t get silently infected with SARS-CoV-2 and pass it on, potentially sickening people who aren’t immune. Those who are infected but never […]